{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:13:19Z","timestamp":1778249599544,"version":"3.51.4"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["21-15-00213"],"award-info":[{"award-number":["21-15-00213"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.biopha.2023.114683","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T11:35:30Z","timestamp":1680867330000},"page":"114683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The spectrum of cell death in sarcoma"],"prefix":"10.1016","volume":"162","author":[{"given":"Elizaveta","family":"Belyaeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Loginova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett A.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian S.","family":"Goldlust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arbind","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Timashev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0818-0363","authenticated-orcid":false,"given":"Ilya","family":"Ulasov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2023.114683_bib1","article-title":"Outcomes of wide resection of soft-tissue sarcoma of the extremity: a retrospective analysis","volume":"14","author":"Sheoran","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.biopha.2023.114683_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2045-3329-3-10","article-title":"Mesenchymal stem cell transformation and sarcoma genesis","volume":"3","author":"Xiao","year":"2013","journal-title":"Clin. Sarcoma Res"},{"issue":"2","key":"10.1016\/j.biopha.2023.114683_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jcb.22701","article-title":"Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton","volume":"111","author":"Chanda","year":"2010","journal-title":"J. Cell Biochem"},{"issue":"1","key":"10.1016\/j.biopha.2023.114683_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41392-021-00647-8","article-title":"Molecular mechanisms underpinning sarcomas and implications for current and future therapy","volume":"6","author":"Damerell","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"4","key":"10.1016\/j.biopha.2023.114683_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrclinonc.2016.183","article-title":"Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy","volume":"14","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114683_bib6","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026104","article-title":"The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression","volume":"6","author":"Chen","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med"},{"issue":"3","key":"10.1016\/j.biopha.2023.114683_bib7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1073\/pnas.98.3.781","article-title":"DNA replication blockade impairs p53-transactivation","volume":"98","author":"Takimoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biopha.2023.114683_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/humu.22552","article-title":"TP53 mutations in human cancer: database reassessment and prospects for the next decade","volume":"35","author":"Leroy","year":"2014","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.biopha.2023.114683_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008642","article-title":"The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss","volume":"16","author":"Setty","year":"2020","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.biopha.2023.114683_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1755-8166-5-26","article-title":"Molecular cytogenetic characterization of undifferentiated embryonal sarcoma of the liver: a case report and literature review","volume":"5","author":"Hu","year":"2012","journal-title":"Mol. Cytogenet"},{"issue":"6","key":"10.1016\/j.biopha.2023.114683_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/gcc.20864","article-title":"High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis","volume":"50","author":"Paulson","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2023.114683_bib12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0955-0674(03)00003-6","article-title":"Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation","volume":"15","author":"Brooks","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2023.114683_bib13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4161\/cc.9.2.10493","article-title":"Defective autophagy control by the p53 rheostat in cancer","volume":"9","author":"Galluzzi","year":"2010","journal-title":"Cell Cycle"},{"issue":"10","key":"10.1016\/j.biopha.2023.114683_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrc2715","article-title":"p53 and metabolism","volume":"9","author":"Vousden","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2023.114683_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.761080","article-title":"p53 modulation of autophagy signaling in cancer therapies: perspectives mechanism and therapeutic targets","volume":"10","author":"Rahman","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114683_bib16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2005.07.002","article-title":"Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy","volume":"122","author":"Pattingre","year":"2005","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2023.114683_bib17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tcb.2010.02.007","article-title":"p53 and ARF: unexpected players in autophagy","volume":"20","author":"Balaburski","year":"2010","journal-title":"Trends Cell Biol."},{"issue":"19","key":"10.1016\/j.biopha.2023.114683_bib18","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.4161\/cc.7.19.6751","article-title":"Mutant p53 protein localized in the cytoplasm inhibits autophagy","volume":"7","author":"Morselli","year":"2008","journal-title":"Cell Cycle"},{"issue":"17","key":"10.1016\/j.biopha.2023.114683_bib19","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1158\/0008-5472.CAN-07-6145","article-title":"EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma","volume":"68","author":"Ban","year":"2008","journal-title":"Cancer Res"},{"issue":"22","key":"10.1016\/j.biopha.2023.114683_bib20","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1158\/0008-5472.CAN-14-1736","article-title":"Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma","volume":"74","author":"Ban","year":"2014","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.biopha.2023.114683_bib21","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1158\/0008-5472.CAN-03-1045","article-title":"p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53","volume":"64","author":"Magro","year":"2004","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.114683_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13018-021-02372-y","article-title":"The role of Notch ligand Jagged1 in osteosarcoma proliferation, metastasis, and recurrence","volume":"16","author":"Zhang","year":"2021","journal-title":"J. Orthop. Surg. Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.114683_bib23","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.220004","article-title":"Notch signalling in healthy and diseased vasculature","volume":"12","author":"Del Gaudio","year":"2022","journal-title":"Open Biol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114683_bib24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ccell.2018.07.009","article-title":"Notch signaling in the tumor microenvironment","volume":"34","author":"Meurette","year":"2018","journal-title":"Cancer Cell"},{"issue":"7579","key":"10.1016\/j.biopha.2023.114683_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature16064","article-title":"Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer","volume":"527","author":"Zheng","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2023.114683_bib26","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1158\/0008-5472.CAN-06-3958","article-title":"Notch signaling, gamma-secretase inhibitors, and cancer therapy","volume":"67","author":"Shih","year":"2007","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2023.114683_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ccr.2014.05.029","article-title":"The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation","volume":"26","author":"Tremblay","year":"2014","journal-title":"Cancer Cell"},{"issue":"23","key":"10.1016\/j.biopha.2023.114683_bib28","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1158\/1078-0432.CCR-11-1004","article-title":"Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis","volume":"17","author":"Belyea","year":"2011","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2023.114683_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14023","article-title":"Notch1 regulated autophagy controls survival and suppressor activity of activated murine T-regulatory cells","volume":"5","author":"Marcel","year":"2016","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.biopha.2023.114683_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/bpa.12343","article-title":"Targeting notch signaling and autophagy increases cytotoxicity in glioblastoma neurospheres","volume":"26","author":"Natsumeda","year":"2016","journal-title":"Brain Pathol."},{"issue":"10","key":"10.1016\/j.biopha.2023.114683_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12032-017-1039-6","article-title":"Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy","volume":"34","author":"Li","year":"2017","journal-title":"Med Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2023.114683_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1349-7006.2011.02154.x","article-title":"Notch1 promotes glioma cell migration and invasion by stimulating beta-catenin and NF-kappaB signaling via AKT activation","volume":"103","author":"Zhang","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2023.114683_bib33","unstructured":"Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa: Reducing the Treatment Gap, Improving Quality of Care: Workshop Summary, Washington (DC), 2010."},{"issue":"1","key":"10.1016\/j.biopha.2023.114683_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","article-title":"The activation of Akt\/PKB signaling pathway and cell survival","volume":"9","author":"Song","year":"2005","journal-title":"J. Cell Mol. Med"},{"issue":"7","key":"10.1016\/j.biopha.2023.114683_bib35","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.114683_bib36","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12935-019-1054-0","article-title":"Blocking AMPK\/ULK1-dependent autophagy promoted apoptosis and suppressed colon cancer growth","volume":"19","author":"Liu","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.biopha.2023.114683_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","article-title":"Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery","volume":"91","author":"Datta","year":"1997","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.biopha.2023.114683_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113312","article-title":"Synthetic MIR143-3p suppresses cell growth in rhabdomyosarcoma cells by interrupting RAS pathways including PAX3-FOXO1","volume":"12","author":"Sugito","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biopha.2023.114683_bib39","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/sj.bjc.6603952","article-title":"PDK-1\/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound","volume":"97","author":"Cen","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.biopha.2023.114683_bib40","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2174\/138945011796150280","article-title":"FOXO1: a potential target for human diseases","volume":"12","author":"Lu","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biopha.2023.114683_bib41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejphar.2014.07.054","article-title":"3beta-Acetyl tormentic acid reverts MRP1\/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity","volume":"741","author":"Rocha Gda","year":"2014","journal-title":"Eur. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2023.114683_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23102","article-title":"The RAS-PI3K-AKT-NF-kappaB pathway transcriptionally regulates the expression of BCL2 family and IAP family genes and inhibits apoptosis in fibrous epulis","volume":"34","author":"Jiang","year":"2020","journal-title":"J. Clin. Lab Anal."},{"issue":"3","key":"10.1016\/j.biopha.2023.114683_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00204-014-1448-7","article-title":"The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update","volume":"89","author":"Siddiqui","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2023.114683_bib44","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008722","article-title":"Multiple functions of BCL-2 family proteins","volume":"5","author":"Hardwick","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114683_bib45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1097-2765(02)00482-3","article-title":"Mechanisms of caspase activation and inhibition during apoptosis","volume":"9","author":"Shi","year":"2002","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.biopha.2023.114683_bib46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.pai.0000173052.37673.95","article-title":"Immunohistochemical analysis of embryonal sarcoma of the liver","volume":"14","author":"Kiani","year":"2006","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2023.114683_bib47","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1038\/onc.2009.51","article-title":"The autophagy effector Beclin 1: a novel BH3-only protein","volume":"27","author":"Sinha","year":"2008","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biopha.2023.114683_bib48","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4161\/auto.4237","article-title":"BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2\/Bcl-X(L)","volume":"3","author":"Maiuri","year":"2007","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.biopha.2023.114683_bib49","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/cdd.2013.45","article-title":"Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes","volume":"20","author":"Basit","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2023.114683_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/326210","article-title":"Cell death pathways as therapeutic targets in rhabdomyosarcoma","volume":"2012","author":"Fulda","year":"2012","journal-title":"Sarcoma"},{"issue":"1","key":"10.1016\/j.biopha.2023.114683_bib51","first-page":"61","article-title":"Genetic and molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes","volume":"24","author":"Pazzaglia","year":"2009","journal-title":"Histol. Histopathol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114683_bib52","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.molcel.2021.01.033","article-title":"Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis","volume":"81","author":"Mukherjee","year":"2021","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2023.114683_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","article-title":"Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome","volume":"257","author":"Bradley","year":"2005","journal-title":"J. Intern Med"},{"issue":"5","key":"10.1016\/j.biopha.2023.114683_bib54","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.bjc.6602994","article-title":"Tumours and tremors: how PTEN regulation underlies both","volume":"94","author":"Kim","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2023.114683_bib55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.biochem.70.1.247","article-title":"PTEN and myotubularin: novel phosphoinositide phosphatases","volume":"70","author":"Maehama","year":"2001","journal-title":"Annu Rev. Biochem"},{"key":"10.1016\/j.biopha.2023.114683_bib56","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1038\/ncomms9388","article-title":"PTEN regulates cilia through Dishevelled","volume":"6","author":"Shnitsar","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.114683_bib57","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1038\/ncomms8557","article-title":"Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma","volume":"6","author":"Seki","year":"2015","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2023.114683_bib58","article-title":"The perfect PTEN - transcriptional regulation by PTEN dictates sarcoma identity","volume":"8","author":"Langdon","year":"2021","journal-title":"Mol. Cell Oncol."},{"issue":"Pt 8","key":"10.1016\/j.biopha.2023.114683_bib59","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1242\/jcs.136259","article-title":"RAGE signaling deficiency in rhabdomyosarcoma cells causes upregulation of PAX7 and uncontrolled proliferation","volume":"127","author":"Riuzzi","year":"2014","journal-title":"J. Cell Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.114683_bib60","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1101\/gad.2016111","article-title":"Pancreatic cancers require autophagy for tumor growth","volume":"25","author":"Yang","year":"2011","journal-title":"Genes Dev."},{"issue":"18","key":"10.1016\/j.biopha.2023.114683_bib61","doi-asserted-by":"crossref","first-page":"18384","DOI":"10.1074\/jbc.M313561200","article-title":"Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1","volume":"279","author":"Scarlatti","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.biopha.2023.114683_bib62","doi-asserted-by":"crossref","first-page":"8182","DOI":"10.1073\/pnas.1217730110","article-title":"In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction","volume":"110","author":"Shima","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.biopha.2023.114683_bib63","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/CAD.0b013e328364312f","article-title":"The tricyclic antidepressant amitriptyline is cytotoxic to HTB114 human leiomyosarcoma and induces p75(NTR)-dependent apoptosis","volume":"24","author":"Pula","year":"2013","journal-title":"Anticancer Drugs"},{"issue":"8","key":"10.1016\/j.biopha.2023.114683_bib64","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1158\/0008-5472.CAN-12-3023","article-title":"SRC signaling is crucial in the growth of synovial sarcoma cells","volume":"73","author":"Michels","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.114683_bib65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/bse0470099","article-title":"Mitochondria in cell death","volume":"47","author":"Parsons","year":"2010","journal-title":"Essays Biochem"},{"issue":"6205","key":"10.1016\/j.biopha.2023.114683_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/science.1248012","article-title":"Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control","volume":"346","author":"Clevers","year":"2014","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.biopha.2023.114683_bib67","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-018-0100-2","article-title":"Notch and interacting signalling pathways in cardiac development, disease, and regeneration","volume":"15","author":"MacGrogan","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"10","key":"10.1016\/j.biopha.2023.114683_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/biom9100608","article-title":"The roles of notch signaling in liver development and disease","volume":"9","author":"Adams","year":"2019","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.biopha.2023.114683_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/genes8060151","article-title":"MYC deregulation in primary human cancers","volume":"8","author":"Kalkat","year":"2017","journal-title":"Genes"},{"issue":"3","key":"10.1016\/j.biopha.2023.114683_bib70","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/81583","article-title":"Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers","volume":"26","author":"Jacobs","year":"2000","journal-title":"Nat. Genet"},{"issue":"4","key":"10.1016\/j.biopha.2023.114683_bib71","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0092-8674(01)00247-1","article-title":"TBX1 is responsible for cardiovascular defects in velo-cardio-facial\/DiGeorge syndrome","volume":"104","author":"Merscher","year":"2001","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2023.114683_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.11","article-title":"The T-box transcription factor 3 is a promising biomarker and a key regulator of the oncogenic phenotype of a diverse range of sarcoma subtypes","volume":"5","author":"Willmer","year":"2016","journal-title":"Oncogenesis"},{"issue":"3","key":"10.1016\/j.biopha.2023.114683_bib73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1247\/csf.28.195","article-title":"c-myc induces autophagy in rat 3Y1 fibroblast cells","volume":"28","author":"Tsuneoka","year":"2003","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.biopha.2023.114683_bib74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1476-4598-5-31","article-title":"Down-regulation of c-Myc following MEK\/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors","volume":"5","author":"Marampon","year":"2006","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2023.114683_bib75","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1158\/1535-7163.MCT-08-0570","article-title":"MEK\/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma","volume":"8","author":"Marampon","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.biopha.2023.114683_bib76","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.devcel.2008.02.003","article-title":"Hedgehog signaling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression","volume":"14","author":"Mak","year":"2008","journal-title":"Dev. Cell"},{"issue":"6828","key":"10.1016\/j.biopha.2023.114683_bib77","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35069099","article-title":"Hedgehog acts as a somatic stem cell factor in the Drosophila ovary","volume":"410","author":"Zhang","year":"2001","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.biopha.2023.114683_bib78","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/1947601910385449","article-title":"Reduction of human embryonal rhabdomyosarcoma tumor growth by inhibition of the hedgehog signaling pathway","volume":"1","author":"Tostar","year":"2010","journal-title":"Genes Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2023.114683_bib79","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s10571-020-00891-6","article-title":"GANT-61 induces autophagy and apoptosis in glioblastoma cells despite their heterogeneity","volume":"41","author":"Carballo","year":"2021","journal-title":"Cell Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114683_bib80","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ccr.2013.11.015","article-title":"RAS and ROS in rhabdomyosarcoma","volume":"24","author":"Zhang","year":"2013","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.biopha.2023.114683_bib81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20061489","article-title":"Exploring the specificity of the PI3K family inhibitor LY294002","volume":"404","author":"Gharbi","year":"2007","journal-title":"Biochem J."},{"issue":"5","key":"10.1016\/j.biopha.2023.114683_bib82","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccr.2006.03.029","article-title":"A dual PI3 kinase\/mTOR inhibitor reveals emergent efficacy in glioma","volume":"9","author":"Fan","year":"2006","journal-title":"Cancer Cell"},{"issue":"41","key":"10.1016\/j.biopha.2023.114683_bib83","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1038\/onc.2008.246","article-title":"Drug discovery approaches targeting the PI3K\/Akt pathway in cancer","volume":"27","author":"Garcia-Echeverria","year":"2008","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2023.114683_bib84","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/0008-5472.CAN-07-0669","article-title":"A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity","volume":"68","author":"Garlich","year":"2008","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.biopha.2023.114683_bib85","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat. Rev. Drug Disco"},{"issue":"9","key":"10.1016\/j.biopha.2023.114683_bib86","first-page":"4528","article-title":"Repurposing of posaconazole as a hedgehog\/SMO signaling inhibitor for embryonal rhabdomyosarcoma therapy","volume":"11","author":"Sun","year":"2021","journal-title":"Am. J. Cancer Res"},{"issue":"10","key":"10.1016\/j.biopha.2023.114683_bib87","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2023.114683_bib88","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/cells1030558","article-title":"Autophagy and transporter-based multi-drug resistance","volume":"1","author":"Kumar","year":"2012","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2023.114683_bib89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biopha.2015.03.009","article-title":"Lapatinib enhances the cytotoxic effects of doxorubicin in MCF-7 tumorspheres by inhibiting the drug efflux function of ABC transporters","volume":"72","author":"Chun","year":"2015","journal-title":"Biomed. Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2023.114683_bib90","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00204-017-1938-5","article-title":"Multiple resistance to carcinogens and xenobiotics: P-glycoproteins as universal detoxifiers","volume":"91","author":"Efferth","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114683_bib91","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.20589","article-title":"ATP-binding cassette superfamily transporter gene expression in human soft tissue sarcomas","volume":"114","author":"Oda","year":"2005","journal-title":"Int J. Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2023.114683_bib92","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1200\/JCO.1997.15.10.3249","article-title":"Evaluation of newer prognostic markers for adult soft tissue sarcomas","volume":"15","author":"Levine","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2023.114683_bib93","first-page":"1329","article-title":"Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression","volume":"27","author":"Li","year":"2005","journal-title":"Int J. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114683_bib94","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.biopha.2023.114683_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046891","article-title":"EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential","volume":"7","author":"Sette","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biopha.2023.114683_bib96","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1007\/s13277-014-1902-4","article-title":"Inhibition of EGFR-induced glucose metabolism sensitizes chondrosarcoma cells to cisplatin","volume":"35","author":"Song","year":"2014","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.biopha.2023.114683_bib97","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1158\/1078-0432.CCR-11-2277","article-title":"Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma","volume":"18","author":"Pahl","year":"2012","journal-title":"Clin. Cancer Res"},{"issue":"9","key":"10.1016\/j.biopha.2023.114683_bib98","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/modpathol.3800636","article-title":"Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma","volume":"19","author":"Ganti","year":"2006","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.biopha.2023.114683_bib99","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fonc.2019.00387","article-title":"Triptolide induces glioma cell autophagy and apoptosis via upregulating the ROS\/JNK and downregulating the Akt\/mTOR signaling pathways","volume":"9","author":"Liu","year":"2019","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2023.114683_bib100","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/15548627.2017.1319039","article-title":"w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1\/3 pathway","volume":"13","author":"Zhang","year":"2017","journal-title":"Autophagy"},{"issue":"14","key":"10.1016\/j.biopha.2023.114683_bib101","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.4161\/cbt.22002","article-title":"EGFR tyrosine kinase inhibition induces autophagy in cancer cells","volume":"13","author":"Fung","year":"2012","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2023.114683_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018691","article-title":"EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.biopha.2023.114683_bib103","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.1158\/0008-5472.CAN-10-0391","article-title":"Differential mechanisms of acquired resistance to insulin-like growth factor-i receptor antibody therapy or to a small-molecule inhibitor, BMS-754807, in a human rhabdomyosarcoma model","volume":"70","author":"Huang","year":"2010","journal-title":"Cancer Res"},{"issue":"24","key":"10.1016\/j.biopha.2023.114683_bib104","doi-asserted-by":"crossref","first-page":"12753","DOI":"10.18632\/oncotarget.2648","article-title":"The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma","volume":"5","author":"Fleuren","year":"2014","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.biopha.2023.114683_bib105","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00432-009-0554-z","article-title":"Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma","volume":"135","author":"Yamamoto","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114683_bib106","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jtho.2020.01.015","article-title":"AXL targeting abrogates autophagic flux and induces immunogenic cell death in drug-resistant cancer cells","volume":"15","author":"Lotsberg","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2023.114683_bib107","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1002\/cam4.2229","article-title":"Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection","volume":"8","author":"Hsu","year":"2019","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.biopha.2023.114683_bib108","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1541-7786.MCR-12-0598","article-title":"Dynamic and nuclear expression of PDGFRalpha and IGF-1R in alveolar Rhabdomyosarcoma","volume":"11","author":"Aslam","year":"2013","journal-title":"Mol. Cancer Res."},{"issue":"7","key":"10.1016\/j.biopha.2023.114683_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071768","article-title":"IGF-1R\/mTOR targeted therapy for ewing sarcoma: a meta-analysis of Five IGF-1R-related trials matched to proteomic and radiologic predictive biomarkers","volume":"12","author":"Amin","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2023.114683_bib110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.biopha.2023.114683_bib111","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.tig.2017.08.004","article-title":"Epithelial-to-mesenchymal transition: epigenetic reprogramming driving cellular plasticity","volume":"33","author":"Skrypek","year":"2017","journal-title":"Trends Genet"},{"issue":"3","key":"10.1016\/j.biopha.2023.114683_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030312","article-title":"EMT regulation by autophagy: a new perspective in glioblastoma biology","volume":"11","author":"Colella","year":"2019","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.biopha.2023.114683_bib113","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1080\/09553002.2017.1325025","article-title":"Autophagy enhanced the radioresistance of non-small cell lung cancer by regulating ROS level under hypoxia condition","volume":"93","author":"Chen","year":"2017","journal-title":"Int J. Radiat. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2023.114683_bib114","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/biolre\/ioy128","article-title":"Autophagy contributes to hypoxia-induced epithelial to mesenchymal transition of endometrial epithelial cells in endometriosis","volume":"99","author":"Liu","year":"2018","journal-title":"Biol. Reprod."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223004717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223004717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:29:44Z","timestamp":1778246984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223004717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":114,"alternative-id":["S0753332223004717"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114683","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The spectrum of cell death in sarcoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114683"}}